← Eichor
Study identifier: NCT06724848 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Pre-COPD Outcomes in Chinese Population

Condition: COPD  ·  Sponsor: AstraZeneca

PhaseN/A
Planned participants850
Who can joinAll sexes, 30 Years to no upper limit
Healthy volunteersNo

About this study

This is an observational study into more comprehensive understanding, including the trajectories of lung function decline, inflammatory/immunological mechanisms on pre-COPD or PRISm, clinical outcomes and relevant endotypes on physician-diagnosed COPD. The sponsor will follow up all participants for 1-year period.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center  ·  1-877-240-9479  ·  information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (14)

Research SiteBeijing, ChinaRecruiting
Research SiteChangsha, ChinaRecruiting
Research SiteChengdu, ChinaRecruiting
Research SiteGuangzhou, ChinaRecruiting
Research SiteHefei, ChinaRecruiting
Research SiteNanjing, ChinaRecruiting
Research SiteNanning, ChinaRecruiting
Research SiteShanghai, ChinaRecruiting
Research SiteShanghai, ChinaNot Yet Recruiting
Research SiteShenyang, ChinaNot Yet Recruiting
Research SiteShenyang, ChinaRecruiting
Research SiteWuhan, ChinaRecruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06724848